MAPT and Alzheimer disease: Programmed Cell Death-Receptor 1 Blockade Reduced Glycogen Synthase Kinase 3 Beta Activity and Tau Hyperphosphorylation and Improved Memory in Alzheimer’s Disease Mice Models